Aminoguanidine has been proven to reduce AGE products production and has helped reducing HbA1C levels.. it is an antiageing drug especially for diabetic patients. it reduces micro and macrovascular complications of DM.
Some AGE breakers are under trial.. they have posed a great hope in reversing nephropathies oin DM.
Consult ur Doc. for this therapy..
Monday, May 3, 2010
TEPLIZUMAB... To Prevent TYPE-1 DM
Hiii.. a v.happy news for TYPE-1 DIABETICS.
Recently Teplizumab Mab.. [Monoclonal Antibodies] entered the Phase-3 Clinical Trials..
It is targeted at protecting the Remaining BETA cells in the Autoimmune Newly Diagnosed Type 1 diabetics.. most suitably within the period of 1-12 weeks of 1st sign of Type-1 DM or the date of 1st contacting the physician 4 d complaints.
If the PHASE-3 trials give wonderful drugs.. The phrase "PREVENTION IS BETTER THAN CURE" would have this therapy as its most novel Application.
Recently Teplizumab Mab.. [Monoclonal Antibodies] entered the Phase-3 Clinical Trials..
It is targeted at protecting the Remaining BETA cells in the Autoimmune Newly Diagnosed Type 1 diabetics.. most suitably within the period of 1-12 weeks of 1st sign of Type-1 DM or the date of 1st contacting the physician 4 d complaints.
If the PHASE-3 trials give wonderful drugs.. The phrase "PREVENTION IS BETTER THAN CURE" would have this therapy as its most novel Application.
Subscribe to:
Comments (Atom)
